"VSports app下载" Premalignant lesions as targets for cancer vaccines
- PMID: 14638849
- PMCID: PMC2194136
- DOI: "VSports在线直播" 10.1084/jem.20031787
VSports app下载 - Premalignant lesions as targets for cancer vaccines
Comment on
-
V体育官网 - Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.J Exp Med. 2003 Dec 1;198(11):1753-7. doi: 10.1084/jem.20031030. Epub 2003 Nov 24. J Exp Med. 2003. PMID: 14638846 Free PMC article.
References
-
- Matzinger, P. 2002. The danger model: a renewed sense of self. Science. 296:301–305. - PubMed (V体育2025版)
-
- Prehn, R.T., and J.M. Main. 1957. Immunity to methylcholantrene-induced sarcomas. J. Natl. Cancer Inst. 18:769–778. - PubMed
-
- Dunn, G.P., A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3:991–998. - PubMed
-
- Darnell, R.B., and J.B. Posner. 2003. Observing the invisible: successful tumor immunity in humans. Nat. Immunol. 4:201. - "V体育2025版" PubMed
Publication types
MeSH terms
- "V体育平台登录" Actions
- Actions (VSports app下载)
- VSports在线直播 - Actions
- Actions (VSports手机版)
Substances
- "VSports" Actions
- VSports在线直播 - Actions
- "V体育安卓版" Actions
- V体育官网 - Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
